| Product Code: ETC9970594 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Minor Cannabinoids Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Minor Cannabinoids Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Minor Cannabinoids Market - Industry Life Cycle |
3.4 United States (US) Minor Cannabinoids Market - Porter's Five Forces |
3.5 United States (US) Minor Cannabinoids Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 United States (US) Minor Cannabinoids Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 United States (US) Minor Cannabinoids Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing consumer awareness about the potential health benefits of minor cannabinoids |
4.2.2 Growing acceptance of cannabis-derived products for medicinal and wellness purposes |
4.2.3 Legalization of hemp and CBD products, leading to a wider acceptance of minor cannabinoids |
4.3 Market Restraints |
4.3.1 Regulatory uncertainties and evolving legal landscape surrounding cannabinoids |
4.3.2 Lack of standardized quality control measures for minor cannabinoids products |
5 United States (US) Minor Cannabinoids Market Trends |
6 United States (US) Minor Cannabinoids Market, By Types |
6.1 United States (US) Minor Cannabinoids Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Minor Cannabinoids Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 United States (US) Minor Cannabinoids Market Revenues & Volume, By Cannabigerol, 2021- 2031F |
6.1.4 United States (US) Minor Cannabinoids Market Revenues & Volume, By Cannabichromene, 2021- 2031F |
6.1.5 United States (US) Minor Cannabinoids Market Revenues & Volume, By Cannabinol, 2021- 2031F |
6.1.6 United States (US) Minor Cannabinoids Market Revenues & Volume, By Tetrahydrocannabivarin, 2021- 2031F |
6.2 United States (US) Minor Cannabinoids Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Minor Cannabinoids Market Revenues & Volume, By Inflammation, 2021- 2031F |
6.2.3 United States (US) Minor Cannabinoids Market Revenues & Volume, By Pain Management, 2021- 2031F |
6.2.4 United States (US) Minor Cannabinoids Market Revenues & Volume, By Neurological Disorders, 2021- 2031F |
6.2.5 United States (US) Minor Cannabinoids Market Revenues & Volume, By Cancer, 2021- 2031F |
6.2.6 United States (US) Minor Cannabinoids Market Revenues & Volume, By Others, 2021- 2031F |
7 United States (US) Minor Cannabinoids Market Import-Export Trade Statistics |
7.1 United States (US) Minor Cannabinoids Market Export to Major Countries |
7.2 United States (US) Minor Cannabinoids Market Imports from Major Countries |
8 United States (US) Minor Cannabinoids Market Key Performance Indicators |
8.1 Number of clinical trials and research studies conducted on minor cannabinoids |
8.2 Adoption rate of minor cannabinoids products by mainstream retailers |
8.3 Amount of investment in research and development for minor cannabinoids formulations |
9 United States (US) Minor Cannabinoids Market - Opportunity Assessment |
9.1 United States (US) Minor Cannabinoids Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 United States (US) Minor Cannabinoids Market Opportunity Assessment, By Application, 2021 & 2031F |
10 United States (US) Minor Cannabinoids Market - Competitive Landscape |
10.1 United States (US) Minor Cannabinoids Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Minor Cannabinoids Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here